← All trials
NCT04993391
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2021
- Primary completion
- Jun 18, 2024
- Completion date
- Aug 18, 2024
- First posted
- Aug 6, 2021
- Last posted
- Aug 6, 2021
- Enrollment
- 156
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Shanghai Junshi Bioscience Co.,Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.